Lupin has reported results for fourth quarter (Q4) and year ended March 31, 2023.

The company has reported net profit of Rs 119.01 crore for the quarter under review as compared to net loss of Rs 35.89 crore for the same quarter in the previous year. Total income of the company increased by 0.70% at Rs 2,891.57 crore for Q4FY23 as compared to Rs 2,871.54 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported net profit of Rs 242.39 crore for fourth quarter ended March 31, 2023 as compared to net loss of Rs 511.73 crore for the same quarter in the previous year. Total income of the company increased by 14.59% at Rs 4,467.35 crore for Q4FY23 as compared to Rs 3,898.71 crore for the corresponding quarter previous year.

For the year ended March 31, 2023, the company has reported net profit of Rs 425.21 crore as compared to net loss of Rs 188.70 crore for the previous year. However, total income of the company decreased by 4.80% at Rs 11,350.09 crore for year under review as compared to Rs 11,922.09 crore for year ended March 31, 2022.

For the year ended March 31, 2023, on the consolidated basis, the company has reported net profit of Rs 447.69 crore as compared to net loss of Rs 1,509.36 crore for the previous year. Total income of the company increased by 1.01% at Rs 16,715.02 crore for year under review as compared to Rs 16,547.17 crore for year ended March 31, 2022.

Lupin Share Price

2179.00 2.75 (0.13%)
19-Jan-2026 12:53 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1683.80
Dr. Reddys Lab 1173.30
Cipla 1391.20
Zydus Lifesciences 870.50
Lupin 2179.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×